Inhibrx Biosciences, Inc. Profile Avatar - Palmy Investing

Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate tar…

Biotechnology
US, La Jolla [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Inhibrx Biosciences, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Inhibrx Biosciences, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Inhibrx Biosciences, Inc..

End of INBX's Analysis
CIK: 1739614 CUSIP: 45720L107 ISIN: US45720L1070 LEI: - UEI: -
Secondary Listings
INBX has no secondary listings inside our databases.